A detailed history of Signature Estate & Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 1,278 shares of LLY stock, worth $955,956. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,278
Previous 1,217 5.01%
Holding current value
$955,956
Previous $1.1 Million 2.82%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $47,100 - $58,561
61 Added 5.01%
1,278 $1.13 Million
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $882,166 - $1.11 Million
1,217 New
1,217 $1.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Signature Estate & Investment Advisors LLC Portfolio

Follow Signature Estate & Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.